Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects June 15, 2011
In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin 2A Receptor Binding in MDMA and Hallucinogen Users June 6, 2011
β-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites May 6, 2011
Consumption of Ayahuasca by Children and Pregnant Women: Medical Controversies and Religious Perspectives April 8, 2011
The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations March 1, 2011
